Sio Gene Therapies Inc. Common Stock
SIOX
SIOX was delisted on the 22nd of March, 2023.
71 hedge funds and large institutions have $1.29B invested in Sio Gene Therapies Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 19 closing their positions.
148% more call options, than puts
Call options by funds: $3.08M | Put options by funds: $1.24M
129% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 7
100% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 19
37% more funds holding
Funds holding: 52 → 71 (+19)
35% less capital invested
Capital invested by funds: $1.99B → $1.29B (-$696M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.5M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$16.7M |
| 3 |
DM
Deerfield Management
New York
|
+$7.1M |
| 4 |
Blackstone Inc
New York
|
+$5.18M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWG
Alpha Wave Global
New York
|
-$20.4M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$19.4M |
| 3 |
LCP
Lamond Capital Partners
San Francisco,
California
|
-$14.1M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$4.62M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$3.82M |
SIOX Hedge Fund Activity: Q3 2015 in Review
71 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q3 2015, worth a combined $1.29B — down 35% from $1.99B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new SIOX positions and 19 closed out — a net gain of 19 holders — while 16 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $18.5M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $20.4M sold.
- 71 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q3 2015, up from 52 in Q2 2015.
- Funds reported $1.29B of Sio Gene Therapies Inc. Common Stock stock for Q3 2015, down 35% quarter-over-quarter.
- 38 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q3 2015 and 19 closed out, a net change of +19 holders.
- The largest Sio Gene Therapies Inc. Common Stock buyer in Q3 2015 was Fidelity Investments, an estimated $18.5M added.
- The largest Sio Gene Therapies Inc. Common Stock seller in Q3 2015 was Alpha Wave Global, an estimated $20.4M sold.
Based on aggregated 13F filings for Q3 2015.